Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-04-14 Sale |
2023-04-18 8:57 pm |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
2,190,549 | $24.32 | $53,274,152 | 15,994,428 (Direct) |
View |
2023-02-10 Sale |
2023-02-14 7:19 pm |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
75,985 | $10.09 | $766,549 | 3,083,191 (Indirect Direct) |
View |
2023-02-10 Sale |
2023-02-14 7:16 pm |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
4,500 | $10 | $45,005 | 0 (Direct) |
View |
2023-02-10 Sale |
2023-02-14 7:13 pm |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
75,835 | $10.09 | $765,003 | 3,479,325 (Direct) |
View |
2023-01-18 Sale |
2023-01-20 8:00 pm |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
24,165 | $10.27 | $248,063 | 3,087,605 (Direct) |
View |
2023-01-18 Sale |
2023-01-20 8:00 pm |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
24,015 | $10.27 | $246,584 | 2,891,088 (Indirect Direct) |
View |
2023-01-18 Sale |
2023-01-20 4:10 pm |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
3,000,000 | $9.4 | $28,200,000 | 11,879,023 (Direct) |
View |
2022-12-29 Sale |
2022-12-30 4:01 pm |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
187,000 | $10.26 | $1,918,601 | 2,915,103 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-27 Equity Swap |
2023-04-28 4:18 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
15,567,497 | $0 | 0 (Direct) |
View |
2023-04-27 Equity Swap |
2023-04-27 6:07 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Pisano Wayne Director |
7,500 | $0 | 0 (Direct) |
View |
2023-04-27 Equity Swap |
2023-04-27 6:06 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
2,570,050 | $0 | 0 (Direct) |
View |
2023-04-27 Equity Swap |
2023-04-27 6:02 pm |
N/A N/A |
Provention Bio Inc. | PRVB | CATLIN AVERY W Director |
10,000 | $0 | 0 (Indirect) |
View |
2023-04-27 Equity Swap |
2023-04-27 6:01 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Ramos Eleanor Chief Medical Officer |
70,000 | $0 | 0 (Direct) |
View |
2023-04-27 Equity Swap |
2023-04-27 6:01 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
2,573,000 | $0 | 0 (Direct) |
View |
2023-04-20 Gift |
2023-04-24 4:18 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
426,931 | $0 | 15,567,497 (Direct) |
View |
2023-04-14 Exercise |
2023-04-18 8:57 pm |
2022-07-13 2027-07-13 |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
8,879,023 | $0 | 15,994,428 (Direct) |
View |
2023-04-14 Exercise |
2023-04-18 8:57 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
8,879,023 | $6 | 15,994,428 (Direct) |
View |
2023-04-13 Gift |
2023-04-14 6:10 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
1,500,000 | $0 | 146,000 (Direct) |
View |
2023-04-13 Gift |
2023-04-14 5:24 pm |
N/A N/A |
Provention Bio Inc. | PRVB | CATLIN AVERY W Director |
10,000 | $0 | 20,000 (Direct) |
View |
2023-04-04 Gift |
2023-04-04 8:10 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
218,651 | $0 | 3,426,931 (Direct) |
View |
2023-03-31 Other |
2023-04-04 8:10 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner |
3,000,000 | $0 | 3,426,931 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 7:19 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
75,985 | $2.5 | 3,083,191 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 7:19 pm |
N/A 2027-04-25 |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
75,985 | $0 | 3,083,191 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 7:13 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
75,835 | $2.5 | 3,479,325 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 7:13 pm |
N/A 2027-04-25 |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
75,835 | $0 | 3,479,325 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 8:00 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
24,165 | $2.5 | 3,087,605 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 8:00 pm |
N/A 2027-04-25 |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
24,165 | $0 | 3,087,605 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 8:00 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
24,015 | $2.5 | 2,891,088 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 8:00 pm |
N/A 2027-04-25 |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
24,015 | $0 | 2,891,088 (Direct) |
View |
2023-01-17 Option Award |
2023-01-18 4:01 pm |
N/A 2033-01-17 |
Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO |
700,000 | $0 | 700,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:17 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Vogel Justin Chief Accounting Officer |
84,000 | $0 | 84,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:16 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Ramos Eleanor Chief Medical Officer |
210,000 | $0 | 210,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:15 pm |
2023-01-10 2031-12-16 |
Provention Bio Inc. | PRVB | Yi Miyoko Christina Chief Operations Officer |
208,000 | $0 | 409,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:14 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Osorio Benedict Chief Quality Officer |
187,000 | $0 | 187,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:13 pm |
2023-01-10 2032-09-15 |
Provention Bio Inc. | PRVB | O'Brien Sarah Chief People Officer |
108,000 | $0 | 208,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:12 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
210,000 | $0 | 210,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:11 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:10 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:10 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Chauche Thierry Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 4:31 pm |
N/A 2033-01-03 |
Provention Bio Inc. | PRVB | Jain Rita Director |
66,000 | $0 | 66,000 (Direct) |
View |
Ownership |
2023-01-05 4:26 pm |
N/A 2028-07-19 |
Provention Bio Inc. | PRVB | Vogel Justin Chief Accounting Officer |
0 | $0 | 329,185 (Direct) |
View |
2022-12-29 Exercise |
2022-12-30 4:01 pm |
N/A N/A |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
187,000 | $2.5 | 2,915,103 (Direct) |
View |
2022-12-29 Exercise |
2022-12-30 4:01 pm |
N/A 2027-04-25 |
Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer |
187,000 | $0 | 2,915,103 (Direct) |
View |